CD274 and cancer: In conclusion, the study delineated the immunotherapeutic predictive versus prognostic effect of metastatic-organ landscape for advanced NSCLC patients in a PD-L1-dependent manner, which helped to improve the understanding of organ-specific antitumor immunity in cancer immunotherapy.